.png)
.png)
Professor
University of Maryland School of Medicine Center for Vaccine Development and Global Health
Disclosure(s): No financial relationships to disclose
I have over 25 years of experience in infectious diseases and vaccine science, policy & leadership. My capabilities range from proficiency in epidemiology and clinicals trials to expertise in vaccine research & development, partnerships with developing country vaccine manufacturers, & knowledge & experience with domestic & international regulatory practices. My vaccine research on Covid-19, influenza, rotavirus, pertussis, and typhoid vaccines, among others, has advanced science and influenced policy. As a PI of a Collaborative Influenza Vaccine Innovation Centers (CIVICS) Clinical Core, I collaborate on the design and execution of human challenge studies and clinical trials of broadly reactive influenza vaccines. I co-direct the Coronavirus Prevention Network (CoVPN), a network of NIH-funded sites who participated in the US-supported Phase 3 trials of Covid-19 vaccines. As such, I am part of the strategic team evaluating COVID vaccines and therapeutics in the US, being involved in the conception, design, execution, analysis, and interpretation of these studies. I serve as an ad hoc member of the ACIP working group on SARS-CoV-2 vaccines, and as a scientific advisor for the Oxford University on their ChimpAd vectored-coronavirus vaccine program. As a member of Strategic Advisory Group of Experts (SAGE), I advise the WHO on use of COVID-19 vaccines as data become available. I have been a member of SAGE since 2019.